SPY302.97-0.56 -0.18%
DIA254.35-1.42 -0.56%
IXIC9,368.99-43.37 -0.46%

Black Diamond Therapeutic Q1 EPS $(51.000) Misses $(0.470) Estimate

Black Diamond Therapeutic (NASDAQ:BDTX) reported quarterly losses of $(51.000) per share which missed the analyst consensus estimate of $(0.470) by 10751.06 percent.

Benzinga · 05/12/2020 11:46

Black Diamond Therapeutic (NASDAQ:BDTX) reported quarterly losses of $(51.000) per share which missed the analyst consensus estimate of $(0.470) by 10751.06 percent.